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RESULTS 
METHODS 
 Midbrain monoaminergic projections – 
including dorsal raphe nucleus (DRN),  
     locus coeruleus (LC)1, and ventral  
     tegmental area (VTA) are of crucial    
     theoretical significance for mood disorders 
 Learned helplessness associated with  
     enhanced metabolic activity in the  
     midbrain (dorsal raphe) of rodents2 
 However, little human neuroimaging 
evidence supports involvement of 
monoaminergic projections in illness 
severity prediction 
 Present study: Arterial Spin Labelling  
     (ASL) measure of cerebral blood flow (CBF)  
     within whole brain during period of rest  
     in  distressed and healthy young adults  
     varying on anxiety/anhedonia dimensions 
 
 
Participants 
36 distressed (DS) and 34 healthy controls (HC) 
Resting State Acquisition 
 
                                            Participants told to  
                                            relax and watch fixation 
                                            cross for six  minutes 
                                               
Neural Measures 
 Blood flow was measured via multiband 
pseudo continuous ASL sequence 
 Regional cerebral perfusion data was 
collected with 25 slices, multiband factor=5, 
4mm slice thickness, FA=90, 64x64 resolution 
FOV=192x912, TR/TE=3.5s/19ms, labeling 
time=1.5s and postlabeling delay=1.7s.  
 Data was processed using Statistical 
Parametric Mapping (SPM) 
 
Demographics DS HC Statistics 
Age (years) 22.2 + 2.1 21.5 + 1.8 T<1 
Sex (M/F) 9/27 15/19 Χ2=2.84, p=0.092 
SES 5.3 + 1.1 5.5 + 1.1 T<1 
Clinical Measures 
MASQ-AD 75.6 + 16.6 
 
50.3 + 9.1 
 
t(68)=-7.9; p<.001 
SHAPS 27.8 + 7.8 18.9 + 5.2 t(68)=-6.7; p<.001 
MASQ GD-A 28.0 + 10.1 
 
13.5 + 2.1 
 
t(68)=-8.2; p<.001 
Mean + SD (Range) or Proportion  
 Anhedonia associated with altered CBF 
     in the midbrain in a young adult   
     population showing heterogeneous    
     symptoms of distress. 
 Anhedonia associated with increased  
     CBF in midbrain, possibly the LC1 
 If key region is in fact LC, current findings 
link noradrenergic projections and 
anhedonia in humans, consistent with 
prior experimental studies of the effect 
     of noradrenergic agents on the human    
     reward system3. 
 
 
 
 
 ASL promising tool to examine enhanced 
local perfusion, potentially reflecting 
underlying midbrain serotonergic activity 
 Learned helplessness studies in rodents 
show similar findings2, but has thus far 
been difficult to investigate in humans.  
Future Directions 
 
Clinical Measures 
 Anhedonia measured via : Mood and Anxiety 
Symptom Questionnaire Anhedonic Depression 
Scale (MASQ-ADS) and Snaith–Hamilton 
Pleasure Scale (SHAPS) as a secondary measure 
 Anxiety measured via: Mood and Anxiety 
Symptom Questionnaire General Distress 
Anxious Symptoms Scale (MASQ GD-A) 
Figures 1 and 2 show regions positively 
correlating with individual differences in 
anhedonia (threshold uncorrected  
p<0.001). 
 
Peak voxels within the midbrain located 
bilaterally  (left: T=5.24, p_FWE=.033,  
x=-12, y=-34, z=-26; right: T=4.96, 
p_FWE=.080, x=9, y=-34, z=-23).  
Limitations 
 Better resolution is needed to 
differentiate between relatively small 
midbrain structures 
 No behavioral measure of anhedonia to 
link with animal work  
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Figure 1 
Figure 2 
Association between anhedonia and midbrain CBF, 
with increasing endorsement of anhedonic symptoms 
predicting enhanced CBF  
